B/BE/19/BVW2 - Informatie fiche bestemd voor het publiek (voorbereid door de kennisgever)

File: 
PDF-pictogram bbe19bvw2_pubinfo_nl.pdf
Trial reference: 
A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector–Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients with Residual FVIII Levels Receiving Prophylactic FVIII
Doc type: 
Information for the public